Poly(ethylene glycol)-coated hexadecylcyanoacrylate nanospheres display a combined effect for brain tumor targeting
- PMID: 12438511
- DOI: 10.1124/jpet.102.039669
Poly(ethylene glycol)-coated hexadecylcyanoacrylate nanospheres display a combined effect for brain tumor targeting
Abstract
The aim of the present study was to evaluate the tumor accumulation of radiolabeled long-circulating poly(ethylene glycol) (PEG)-coated hexadecylcyanoacrylate nanospheres and non-PEG-coated hexadecylcyanoacrylate nanospheres (used as control), after intravenous injection in Fischer rats bearing intracerebrally well established 9L gliosarcoma. Both types of nanospheres showed an accumulation with a retention effect in the 9L tumor. However, long-circulating nanospheres concentrated 3.1 times higher in the gliosarcoma, compared with non-PEG-coated nanospheres. The tumor-to-brain ratio of pegylated nanospheres was found to be 11, which was in accordance with the ratios reported for other carriers tested for brain tumor targeting such as long-circulating liposomes or labels for magnetic resonance imaging. In addition, a 4- to 8-fold higher accumulation of the PEG-coated carriers was observed in normal brain regions, when compared with control nanospheres. Using a simplified pharmacokinetic model, two different mechanisms were proposed to explain this higher concentration of PEG-coated nanospheres in a tumoral brain. 1) in the 9L tumor, the preferential accumulation of pegylated nanospheres was attributable to their slower plasma clearance, relative to control nanospheres. Diffusion/convection was the proposed mechanism for extravasation of the nanospheres in the 9L interstitium, across the altered blood-brain barrier. 2) In addition, PEG-coated nanospheres displayed an affinity with the brain endothelial cells (normal brain region), which may not be considered as the result of a simple diffusion/convection process. The exact underlying mechanism of such affinity deserves further investigation, since it was observed to be as important as specific interactions described for immunoliposomes with the blood-brain barrier.
Similar articles
-
Negative preclinical results with stealth nanospheres-encapsulated Doxorubicin in an orthotopic murine brain tumor model.J Control Release. 2004 Nov 5;100(1):29-40. doi: 10.1016/j.jconrel.2004.07.019. J Control Release. 2004. PMID: 15491808
-
Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model.Anticancer Res. 2009 Jun;29(6):2111-20. Anticancer Res. 2009. PMID: 19528471
-
Oxaliplatin encapsulated in PEG-coated cationic liposomes induces significant tumor growth suppression via a dual-targeting approach in a murine solid tumor model.J Control Release. 2009 Jul 1;137(1):8-14. doi: 10.1016/j.jconrel.2009.02.023. Epub 2009 Mar 12. J Control Release. 2009. PMID: 19285528
-
Polyalkylcyanoacrylate nanoparticles for delivery of drugs across the blood-brain barrier.Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2009 Sep-Oct;1(5):463-74. doi: 10.1002/wnan.5. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2009. PMID: 20049811 Review.
-
Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates.Adv Drug Deliv Rev. 2004 Apr 29;56(8):1177-92. doi: 10.1016/j.addr.2004.01.011. Adv Drug Deliv Rev. 2004. PMID: 15094214 Review.
Cited by
-
Nanomedicine: towards development of patient-friendly drug-delivery systems for oncological applications.Int J Nanomedicine. 2012;7:1043-60. doi: 10.2147/IJN.S25182. Epub 2012 Feb 23. Int J Nanomedicine. 2012. PMID: 22403487 Free PMC article. Review.
-
Ionically fixed polymeric nanoparticles as a novel drug carrier.Pharm Res. 2007 Aug;24(8):1508-16. doi: 10.1007/s11095-007-9269-5. Epub 2007 Mar 23. Pharm Res. 2007. PMID: 17380262
-
Drug Delivery of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) to Target Brain Tumors.Adv Pharm Bull. 2023 Jul;13(3):512-520. doi: 10.34172/apb.2023.062. Epub 2022 Nov 5. Adv Pharm Bull. 2023. PMID: 37646057 Free PMC article. Review.
-
Solid lipid nanoparticles as delivery systems for bromocriptine.Pharm Res. 2008 Jul;25(7):1521-30. doi: 10.1007/s11095-007-9514-y. Epub 2008 Jan 3. Pharm Res. 2008. PMID: 18172580
-
MRI study on reversible and irreversible electroporation induced blood brain barrier disruption.PLoS One. 2012;7(8):e42817. doi: 10.1371/journal.pone.0042817. Epub 2012 Aug 10. PLoS One. 2012. PMID: 22900052 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical